Rapid learning

Hypofractionated radiation therapy

You’ve probably heard the term, but what exactly is hypofractionation? This rapid learning will simplify the science and give you a good understanding of what the term means and which cancers can benefit from this type of radiation therapy.

Learn about the benefits of hypofractionation for patients and the health care system.

Hypofractionation Rapid learning →

Cancer Survivorship

An individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life.​

Our newest rapid learning will give you insight into the complexities of being a cancer survivor, and how to best support the health and wellbeing of a person living with and beyond cancer.

By the end of the module you will be able to:

  • define the term cancer survivor 
  • identify your role in supporting cancer survivors and referring survivors to key resources
  • describe the importance of healthy lifestyle behaviours in improving quality of life
  • outline the importance of survivorship care plans and engaging primary care in survivorship care.

Learn how you could make a difference.

Survivorship Rapid learning →

New to Rapid learning?

Browse our Rapid Learning library.

Oncology basics

An optional prerequisite to ADAC

Oncology basics is the new course we’ve developed to reduce the content overlap throughout ADAC and other eviQ Education courses. It’s for those new to the area of cancer, who may not necessarily be administering antineoplastic drugs. The course represents the new direction for our team in simplifying our content, and we have to say, we’re quite proud of it.

The three-part course will act as an optional prerequisite to ADAC. It’s for learners who are new to the field of oncology and require some extra training and information to get them up to speed before they begin ADAC.

View Oncology basics here →

ADAC update

So much happening on the ADAC front - we had to create a new webpage! Take a look at our new one-stop-shop for ADAC version 4, complete with progress updates for each stream, and a little video hello from the team - from our home offices to yours! We want to assure you we’re still here working away and making some terrific progress towards delivering the new version. We’re hoping you’ll consider contributing too.

View the ADAC webpage  →

How do you do it?

We want to understand the way people across health are interacting with Systemic Anti-Cancer Therapies. Why? So we can design stream-specific content relevant to their roles.

We’d  love your input to this quick user survey and it would be great if you could help circulate it to your colleagues in community nursing, cancer pharmacy and non-cancer settings by sharing this link: https://www.surveymonkey.com/r/adac4.

Take the survey  →

We're finalists!

Our Telephone triage toolkit eLearning package has been selected as a finalist in the Australian Institute of Training and Development (AITD) Excellence Awards 2020 - Best Blended Learning Solution category. 

Winners will be announced in November and we'll let you know how we go. Either way, we're very proud. Of course, we couldn't produce education to this standard without the generous contribution of our fabulous reviewers, so thank you!

Join a review group - Cancer supportive care

Do you have a keen interest in cancer supportive care? 

Interested in earning CPD points?

Then why not join our external review group and get involved in the Cancer supportive care module review?

Module topics include:

  • cancer supportive care
  • supportive care screening and communicating about concerns
  • focused assessment
  • provision of appropriate levels of interventions and/or referral.

If you'd like to learn more, read our information sheet. If you'd like to be involved, please send your expression of interest to CINSW-EviQEd@health.nsw.gov.au and remember to include:

  • your name
  • current workplace
  • current role
  • preferred email address for future contact.

Expressions of interest close 9am Monday the 12th of October.

We've  moved

The Cancer Institute NSW (along with a multitude of NSW Health groups and pillars) has recently relocated to a brand spanking new building at 1 Reserve Road, St Leonards, situated on the traditional lands of the Cammeraygal people. We’re looking forward to meeting our new internal neighbours, and our new next door neighbours at Royal North Shore Hospital. We’re sure we’ll all become good friends.

eviQ updates

eviQ protocol updates

Subscribe to receive content area specific updates direct to your inbox - click here to sign up to eviQ newsletters.

eviQ also lists all recently added protocols and updates made in the past 90 days on their content area homepages: Cancer genetics Haematology and BMT Medical oncology Radiation oncologyClinical resources

eviQ →

As usual...

eviQ Education flyers available for your practice - Featuring a catalogue of all our courses. You can now print your own flyer to display in your workplace.

Rapid Listening series - Listen to our rapid learning series on our website, or listen/subscribe to the podcasts on Spotify or Google Podcasts.

Facilitator training: Register for on-demand facilitator training and/or an online Q & A session webinar:

  • ADAC Q & A session - Wednesday 23rd September 2020 - 2.00 – 3.00 pm (AEST)
  • ADAC Q & A session - Wednesday 21st October 2020 - 2.00 – 3.00 pm (AEST)

View the training calendar here .

Email us on eviqed@eviq.org.au to receive training access or book your Q & A session and receive webinar login details.

 Want to know what's new? Keep an eye on our website newsfeed.

 Share the love: If you have a colleague who may be interested in receiving this update – please invite them to subscribe! If you have a link you'd like to share, think about tweeting it with hashtag #eviQ .



Q: "Is it too late to join an ADAC review group?​"

A: Not at all! We're still welcoming members and looking forward to working with you on the version 4 update.

Register your interest here! →



Did you know?

Women receiving hypofractionation for early breast cancer, experience equal, if not better, efficacy as measured by survival, mortality and recurrence rates?

Learn which other cancers benefit from hypofractionation. 

Go to hypofractionation Rapid learning →